Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06541132 Sponsor: Chongqing Medical University Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06541132
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be older than 18 years of age
  • You must have had a coronary angiography (a procedure to look at the blood vessels of the heart) at the study hospital between August 2022 and December 2023, due to chest pain, chest tightness, or other reasons

Who may not be able to join:

  • Your medical records from the hospital are incomplete
  • You have previously had a coronary stent placed in your heart
  • You did not have an abdominal ultrasound (a scan of the belly area) as part of your care
  • The images from your ultrasound scan were not clear enough to use
  • You have a heart condition that you were born with (congenital heart disease)
  • You have or have had cancer or a tumour
  • You have a thyroid condition (a problem with the gland in your neck that controls hormones)
  • You have or have had an infectious disease (confirm with trial site for specific conditions this includes)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8617815370539

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chongqing Medical University
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
28 April 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

SYNTAX score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov